(S)-N-(1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine, 98%, 10mg

(S,S)-(+)-2,3-Bis(tert-butylmethylphosphino)quinoxaline>98.0%(HPLC)100mg

6-Acetyl-2H-1,4-benzoxazin-3(4H)-one>98.0%(HPLC)(N)5g

Phytantriol (mixture of isomers)>95.0%(GC)5g

(R)-2-(Methylamino)succinic acid, >98%, 100mg

(2R,4S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylic acid, 96%, 500mg

19-(tert-butoxy)-1-(diazyn-1-ium-1-yl)-19-oxo-4,7,10,13,16-pentaoxa-1-azanonadecan-1-ide, 98%, 500mg

3-(Pyrrolidin-3-yl)quinazolin-4(3H)-one, 97%, 2.5g

(2-Chloro-3-methoxyphenyl)boronic acid, 95.0%, 1g

2-Ethyl-1,3,4-oxadiazole, 95.0%, 250mg

2-Cyano-4-methylpyridine 1-oxide, 250mg

4-AMINO-1-[2,3-O-(1-METHYLETHYLIDENE)PENTOFURANOSYL]-1,3,5-TRIAZIN-2(1H)-ONE, 95.0%, 100mg

5-Fluoro-4-methylpyridin-3-amine, 98%, 250mg